Integrated role of Bifidobacterium animalis subsp. lactis supplementation in gut microbiota, immunity, and metabolism of infant rhesus monkeys

mSystems

Volumn 1, Issue 6, 2016, Pages

  He, Xuan ^a   Slupsky, Carolyn M ^a   Dekker, James W ^b   Haggarty, Neill W ^b   Lönnerdal, Bo ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b FONTERRA RESEARCH CENTRE   (New Zealand)

Author keywords

Infant; Metabolome; Microbiome; Nutrition; Probiotics

Indexed keywords

EID: 85041673864     PISSN: None     EISSN: 23795077     Source Type: Journal    
DOI: 10.1128/mSystems.00128-16     Document Type: Article

References (44)

1. O'Sullivan A, He X, McNiven EM, Haggarty NW, Lönnerdal B, Slupsky CM. 2013. Early diet impacts infant rhesus gut microbiome, immunity, and metabolism. J Proteome Res 12:2833-2845. http://dx.doi.org/10.1021/pr4001702.
2. Wells JM, Rossi O, Meijerink M, van Baarlen P. 2011. Epithelial cross talk at the microbiota-mucosal interface. Proc Natl Acad Sci USA 108(Suppl 1):4607-4614. http://dx.doi.org/10.1073/pnas.1000092107.
3. Rosenbaum M, Knight R, Leibel RL. 2015. The gut microbiota in human energy homeostasis and obesity. Trends Endocrinol Metab 26:493-501. http://dx.doi.org/10.1016/j.tem.2015.07.002.
4. Indrio F, Neu J. 2011. The intestinal microbiome of infants and the use of probiotics. Curr Opin Pediatr 23:145-150. http://dx.doi.org/10.1097/MOP.0b013e3283444ccb.
5. Braegger C, Chmielewska A, Decsi T, Kolacek S, Mihatsch W, Moreno L, Pieścik M, Puntis J, Shamir R, Szajewska H, Turck D, van Goudoever J, ESPGHAN Committee on Nutrition. 2011. Supplementation of infant formula with probiotics and/or prebiotics: a systematic review and comment by the ESPGHAN committee on nutrition. J Pediatr Gastroent e r o l N u t r 5 2: 2 3 8-2 5 0. h t t p://d x. d o i. o r g/1 0. 1 0 9 7/MPG.0b013e3181fb9e80.
6. Rupa P, Mine Y. 2012. Recent advances in the role of probiotics in human inflammation and gut health. J Agric Food Chem 60:8249-8256. http://dx.doi.org/10.1021/jf301903t.
7. Meile L, Ludwig W, Rueger U, Gut C, Kaufmann P, Dasen G, Wenger S, Teuber M. 1997. Bifidobacterium lactis sp. nov., a moderately oxygen tolerant species isolated from fermented milk. Syst Appl Microbiol 20: 57-64. http://dx.doi.org/10.1016/S0723-2020(97)80048-3.
8. Masco L, Ventura M, Zink R, Huys G, Swings J. 2004. Polyphasic taxonomic analysis of Bifidobacterium animalis and Bifidobacterium lactis reveals relatedness at the subspecies level: reclassification of Bifidobacterium animalis as Bifidobacterium animalis subsp. animalis subsp. nov. and Bifidobacterium lactis as Bifidobacterium animalis subsp. lactis subsp. nov. Int J Syst Evol Microbiol 54:1137-1143. http://dx.doi.org/10.1099/ijs.0.03011-0.
9. Sanders ME. 2006. Summary of probiotic activities of Bifidobacterium lactis HN019. J Clin Gastroenterol 40:776-783. http://dx.doi.org/10.1097/01.mcg.0000225576.73385.f0.
10. Shu Q, Zhou JS, Rutherfurd KJ, Birtles MJ, Prasad J, Gopal PK, Gill HS. 1999. Probiotic lactic acid bacteria (Lactobacillus acidophilus HN017, Lactobacillus rhamnosus HN001 and Bifidobacterium lactis HN019) have no adverse effects on the health of mice. Int Dairy J 9:831-836. http://dx.doi.org/10.1016/S0958-6946(99)00154-5.
11. Zhou JS, Shu Q, Rutherfurd KJ, Prasad J, Birtles MJ, Gopal PK, Gill HS. 2000. Safety assessment of potential probiotic lactic acid bacterial strains Lactobacillus rhamnosus HN001, Lb. acidophilus HN017, and Bifidobacterium lactis HN019 in BALB/c mice. Int J Food Microbiol 56:87-96. http://dx.doi.org/10.1016/S0168-1605(00)00219-1.
12. Zhou JS, Shu Q, Rutherfurd KJ, Prasad J, Gopal PK, Gill HS. 2000. Acute oral toxicity and bacterial translocation studies on potentially probiotic strains of lactic acid bacteria. Food Chem Toxicol 38:153-161. http://dx.doi.org/10.1016/S0278-6915(99)00154-4.
13. Dekker JW, Wickens K, Black PN, Stanley TV, Mitchell EA, Fitzharris P, Tannock GW, Purdie G, Crane J. 2009. Safety aspects of probiotic bacterial strains Lactobacillus rhamnosus HN001 and Bifidobacterium animalis subsp. lactis HN019 in human infants aged 0-2 years. Int Dairy J 19:149-154. http://dx.doi.org/10.1016/j.idairyj.2008.10.004.
14. O'Sullivan A, He X, McNiven EMS, Hinde K, Haggarty NW, Lonnerdal B, Slupsky CM. 2013. Metabolomic phenotyping validates the infant rhesus monkey as a model of human infant metabolism. J Pediatr Gastroenterol Nutr 56:355-363. http://dx.doi.org/10.1097/MPG.0b013e31827e1f07.
15. Kelleher SL, Casas I, Carbajal N, Lönnerdal B. 2002. Supplementation of infant formula with the probiotic Lactobacillus reuteri and zinc: impact on enteric infection and nutrition in infant rhesus monkeys. J Pediatr Gastroenterol Nutr 35:162-168. http://dx.doi.org/10.1097/00005176-200208000-00011.
16. Kelleher SL, Chatterton D, Nielsen K, Lönnerdal B. 2003. Glycomacropeptide and alpha-lactalbumine supplementation of infant formula affects growth and nutritional status in infant rhesus monkeys. Am J Clin Nutr 77:1261-1268.
17. Kim HK, Rutten NB, Besseling-van der Vaart I, Niers LE, Choi YH, Rijkers GT, van Hemert S. 2015. Probiotic supplementation influences faecal short chain fatty acids in infants at high risk for eczema. Benef Microbes 6:783-790. http://dx.doi.org/10.3920/BM2015.0056.
18. Klein A, Friedrich U, Vogelsang H, Jahreis G. 2008. Lactobacillus acidophilus 74-2 and Bifidobacterium animalis subsp. lactis DGCC 420 modulate unspecific cellular immune response in healthy adults. Eur J Clin Nutr 62:584-593. http://dx.doi.org/10.1038/sj.ejcn.1602761.
19. Liu C, Zhang ZY, Dong K, Guo XK. 2010. Adhesion and immunomodulatory effects of Bifidobacterium lactis HN019 on intestinal epithelial cells INT-407. World J Gastroenterol 16:2283-2290. http://dx.doi.org/10.3748/wjg.v16.i18.2283.
20. Gopal PK, Prasad J, Smart J, Gill HS. 2001. In vitro adherence properties of Lactobacillus rhamnosus DR20 and Bifidobacterium lactis DR10 strains and their antagonistic activity against an enterotoxigenic Escherichia coli. Int J Food Microbiol 67:207-216. http://dx.doi.org/10.1016/S0168-1605(01)00440-8.
21. Shu Q, Lin H, Rutherfurd KJ, Fenwick SG, Prasad J, Gopal PK, Gill HS. 2000. Dietary Bifidobacterium lactis (HN019) enhances resistance to oral Salmonella typhimurium infection in mice. Microbiol Immunol 44: 213-222. http://dx.doi.org/10.1111/j.1348-0421.2000.tb02486.x.
22. Shu Q, Qu F, Gill HS. 2001. Probiotic treatment using Bifidobacterium lactis HN019 reduces weanling diarrhea associated with rotavirus and Escherichia coli infection in a piglet model. J Pediatr Gastroenterol Nutr 33:171-177. http://dx.doi.org/10.1097/00005176-200108000-00014.
23. Shu Q, Gill HS. 2001. A dietary probiotic (Bifidobacterium lactis HN019) reduces the severity of Escherichia coli O157:H7 infection in mice. Med Microbiol Immunol 189:147-152. http://dx.doi.org/10.1007/s430-001-8021-9.
24. Pease JE, Williams TJ. 2006. Chemokines and their receptors in allergic disease. J Allergy Clin Immunol 118:305-318. http://dx.doi.org/10.1016/j.jaci.2006.06.010.
25. Abelius MS, Ernerudh J, Berg G, Matthiesen L, Nilsson LJ, Jenmalm MC. 2011. High cord blood levels of the T-helper 2-associated chemokines CCL17 and CCL22 precede allergy development during the first 6 years of life. Pediatr Res 70:495-500. http://dx.doi.org/10.1203/PDR.0b013e31822f2411.
26. Niers L, Martín R, Rijkers G, Sengers F, Timmerman H, van Uden N, Smidt H, Kimpen J, Hoekstra M. 2009. The effects of selected probiotic strains on the development of eczema (the PandA study). Allergy 64: 1349-1358. http://dx.doi.org/10.1111/j.1398-9995.2009.02021.x.
27. Chorell E, Karlsson Videhult F, Hernell O, Antti H, West CE. 2013. Impact of probiotic feeding during weaning on the serum lipid profile and plasma metabolome in infants. Br J Nutr 110:116-126. http://dx.doi.org/10.1017/S0007114512004618.
28. Millward DJ, Forrester T, Ah-Sing E, Yeboah N, Gibson N, Badaloo A, Boyne M, Reade M, Persaud C, Jackson A. 2000. The transfer of 15N from urea to lysine in the human infant. Br J Nutr 83:505-512.
29. Abubucker S, Segata N, Goll J, Schubert AM, Izard J, Cantarel BL, Rodriguez-Mueller B, Zucker J, Thiagarajan M, Henrissat B, White O, Kelley ST, Methé B, Schloss PD, Gevers D, Mitreva M, Huttenhower C. 2012. Metabolic reconstruction for metagenomic data and its application to the human microbiome. PLoS Comput Biol 8:e1002358. http://dx.doi.org/10.1371/journal.pcbi.1002358.
30. Gill SR, Pop M, Deboy RT, Eckburg PB, Turnbaugh PJ, Samuel BS, Gordon JI, Relman DA, Fraser-Liggett CM, Nelson KE. 2006. Metagenomic analysis of the human distal gut microbiome. Science 312: 1355-1359. http://dx.doi.org/10.1126/science.1124234.
31. Neis EPJG, Dejong CHC, Rensen SS. 2015. The role of microbial amino acid metabolism in host metabolism. Nutrients 7:2930-2946. http://dx.doi.org/10.3390/nu7042930.
32. Locasale JW. 2013. Serine, glycine and one-carbon units: cancer metabolism in full circle. Nat Rev Cancer 13:572-583. http://dx.doi.org/10.1038/nrc3557.
33. Brasili E, Mengheri E, Tomassini A, Capuani G, Roselli M, Finamore A, Sciubba F, Marini F, Miccheli A. 2013. Lactobacillus acidophilus La5 and Bifidobacterium lactis Bb12 induce different age-related metabolic profiles revealed by 1H-NMR spectroscopy in urine and feces of mice. J Nutr 143:1549-1557. http://dx.doi.org/10.3945/jn.113.177105.
34. Martin FP, Sprenger N, Yap IK, Wang Y, Bibiloni R, Rochat F, Rezzi S, Cherbut C, Kochhar S, Lindon JC, Holmes E, Nicholson JK. 2009. Panorganismal gut microbiome-host metabolic crosstalk. J Proteome Res 8:2090-2105. http://dx.doi.org/10.1021/pr801068x.
35. Kostić DA, Dimitrijević DS, Stojanović GS, Palić IR, Dordević AS, Ickovski JD. 2015. Xanthine oxidase: isolation, assays of activity, and inhibition. J Chem 2015:1-8. http://dx.doi.org/10.1155/2015/294858.
36. Bligh EG, Dyer WJ. 1959. A rapid method of total lipid extraction and purification. Can J Biochem Physiol 37:911-917. http://dx.doi.org/10.1139/o59-099.
37. Slupsky CM, Rankin KN, Wagner J, Fu H, Chang D, Weljie AM, Saude EJ, Lix B, Adamko DJ, Shah S, Greiner R, Sykes BD, Marrie TJ. 2007. Investigations of the effects of gender, diurnal variation, and age in human urinary metabolomic profiles. Anal Chem 79:6995-7004. http://dx.doi.org/10.1021/ac0708588.
38. Weljie AM, Newton J, Mercier P, Carlson E, Slupsky CM. 2006. Targeted profiling: quantitative analysis of 1H NMR metabolomics data. Anal Chem 78:4430-4442. http://dx.doi.org/10.1021/ac060209g.
39. Caporaso JG, Kuczynski J, Stombaugh J, Bittinger K, Bushman FD, Costello EK, Fierer N, Peña AG, Goodrich JK, Gordon JI, Huttley GA, Kelley ST, Knights D, Koenig JE, Ley RE, Lozupone CA, McDonald D, Muegge BD, Pirrung M, Reeder J, Sevinsky JR, Turnbaugh PJ, Walters WA, Widmann J, Yatsunenko T, Zaneveld J, Knight R. 2010. QIIME allows analysis of high-throughput community sequencing data. Nat Methods 7:335-336. http://dx.doi.org/10.1038/nmeth.f.303.
40. Edgar RC. 2010. Search and clustering orders of magnitude faster than BLAST. Bioinformatics 26:2460-2461. http://dx.doi.org/10.1093/bioinformatics/btq461.
41. Lozupone C, Knight R. 2005. UniFrac: a new phylogenetic method for comparing microbial communities. Appl Environ Microbiol 71: 8228-8235. http://dx.doi.org/10.1128/AEM.71.12.8228-8235.2005.
42. Vázquez-Baeza Y, Pirrung M, Gonzalez A, Knight R. 2013. Emperor: a tool for visualizing high-throughput microbial community data. Gigascience 2:16. http://dx.doi.org/10.1186/2047-217X-2-16.
43. Yao F, Coquery J, Cao LKA. 2012. Independent principal component analysis for biologically meaningful dimension reduction of large biological data sets. BMC Bioinformatics 13:24. http://dx.doi.org/10.1186/1471-2105-13-24.
44. Wickham H. 2009. ggplot2: elegant graphics for data analysis. Springer, New York, NY.